EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.14.11.27 | [histone H3]-dimethyl-L-lysine36 demethylase |
BxPC-3 cell |
- |
764436 |
1.14.11.65 | [histone H3]-dimethyl-L-lysine9 demethylase |
BxPC-3 cell |
- |
764436 |
1.14.11.66 | [histone H3]-trimethyl-L-lysine9 demethylase |
BxPC-3 cell |
- |
764436 |
1.14.11.69 | [histone H3]-trimethyl-L-lysine36 demethylase |
BxPC-3 cell |
- |
764436 |
1.6.5.2 | NAD(P)H dehydrogenase (quinone) |
BxPC-3 cell |
- |
694519 |
1.8.1.9 | thioredoxin-disulfide reductase |
BxPC-3 cell |
- |
713067 |
2.1.1.348 | mRNA m6A methyltransferase |
BxPC-3 cell |
- |
757908 |
2.3.1.B41 | protein-long-chain fatty-acyl-lysine deacylase (NAD+) |
BxPC-3 cell |
- |
756689 |
2.4.1.102 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase |
BxPC-3 cell |
- |
735883 |
2.4.1.150 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase |
BxPC-3 cell |
- |
758993 |
2.4.1.69 | type 1 galactoside alpha-(1,2)-fucosyltransferase |
BxPC-3 cell |
stable transfeceted with FUT1 cDNA in a pcDNA3 vector |
657509 |
2.4.2.12 | nicotinamide phosphoribosyltransferase |
BxPC-3 cell |
- |
736436 |
2.4.3.4 | beta-galactoside alpha-2,3-sialyltransferase |
BxPC-3 cell |
- |
764905 |
2.7.1.105 | 6-phosphofructo-2-kinase |
BxPC-3 cell |
- |
739045 |
2.7.1.74 | deoxycytidine kinase |
BxPC-3 cell |
- |
706027 |
2.7.10.1 | receptor protein-tyrosine kinase |
BxPC-3 cell |
- |
672875, 672917, 737818 |
2.7.10.1 | receptor protein-tyrosine kinase |
BxPC-3 cell |
Ron is highly expressed |
690303 |
2.7.11.30 | receptor protein serine/threonine kinase |
BxPC-3 cell |
- |
693034 |
2.7.11.30 | receptor protein serine/threonine kinase |
BxPC-3 cell |
pancreatic Smad4 null cell line, expression of Smad2 and Smad3 |
666512 |
2.7.12.2 | mitogen-activated protein kinase kinase |
BxPC-3 cell |
- |
740419 |
2.7.2.3 | phosphoglycerate kinase |
BxPC-3 cell |
pancreatic carcinoma cell line, low amount of enzyme compared to HT-1080 cells |
642295 |
2.8.2.30 | [heparan sulfate]-glucosamine 3-sulfotransferase 3 |
BxPC-3 cell |
- |
724692 |
3.1.3.66 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase |
BxPC-3 cell |
- |
750257 |
3.4.21.117 | stratum corneum chymotryptic enzyme |
BxPC-3 cell |
- |
683325 |
3.4.22.55 | caspase-2 |
BxPC-3 cell |
PS-341 (bortezomib) induces a dose-dependent apoptosis in association with reactive oxygen species generation and cleavage of caspase-2 to its 33- and 14-kDa fragments. PS-341-induced caspase-2 activation is attenuated by a selective pharmacological inhibitor of cathepsin B (R-3032). Caspase-2 regulates mitochondrial permeability |
687504 |
3.4.22.61 | caspase-8 |
BxPC-3 cell |
- |
697381 |
3.4.24.23 | matrilysin |
BxPC-3 cell |
- |
708011 |
3.4.24.B9 | ADAM9 endopeptidase |
BxPC-3 cell |
- |
677587 |
5.3.3.12 | L-dopachrome isomerase |
BxPC-3 cell |
- |
747965 |
5.6.2.2 | DNA topoisomerase (ATP-hydrolysing) |
BxPC-3 cell |
- |
693540 |
6.3.4.5 | argininosuccinate synthase |
BxPC-3 cell |
pancreatic cancer cell line, low ASS expression level |
692659 |
6.3.5.4 | asparagine synthase (glutamine-hydrolysing) |
BxPC-3 cell |
- |
672914 |
7.2.2.13 | Na+/K+-exchanging ATPase |
BxPC-3 cell |
- |
712805 |